Followers | 75 |
Posts | 3712 |
Boards Moderated | 0 |
Alias Born | 04/08/2022 |

Friday, March 14, 2025 11:38:00 AM
Recent RNAZ News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:15:55 PM
- TransCode Therapeutics Successfully Completes Initial Dosing of Patients in Cohort 4 of Phase 1a Clinical Trial; No Dose Limiting Toxicities Reported • PR Newswire (US) • 05/08/2025 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 08:45:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2025 09:20:27 PM
- TransCode Therapeutics Announces Effective Date for 1-for-28 Reverse Stock Split • PR Newswire (US) • 05/05/2025 09:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/02/2025 08:20:28 PM
- TransCode Therapeutics Announces 1-for-28 Reverse Stock Split • PR Newswire (US) • 05/02/2025 08:10:00 PM
- TransCode Therapeutics Reports Further Progress on Phase 1a Clinical Trial with No Dose Limiting Toxicities Reported in Patients with Metastatic Cancer • PR Newswire (US) • 05/01/2025 01:01:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2025 08:17:52 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2025 08:41:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/21/2025 08:40:23 PM
- TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting • PR Newswire (US) • 04/21/2025 08:37:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/16/2025 11:40:11 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2025 08:38:25 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/02/2025 08:58:30 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2025 08:15:44 PM
- TransCode Therapeutics Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial with TTX-MC138 • PR Newswire (US) • 03/27/2025 08:37:00 PM
- TransCode Therapeutics, Inc. Announces Closing of Registered Direct Offering • PR Newswire (US) • 03/25/2025 10:24:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2025 12:15:54 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/25/2025 11:00:52 AM
- TransCode Therapeutics, Inc. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • PR Newswire (US) • 03/24/2025 03:11:00 AM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 03/20/2025 09:16:50 PM
- TransCode Therapeutics Announces Safety Review Committee Approval to Open Fourth Cohort in Phase I/II Clinical Trial • PR Newswire (US) • 03/13/2025 11:47:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2025 09:25:20 PM
- TransCode Therapeutics, Inc. Announces Results of Special Meeting • PR Newswire (US) • 02/25/2025 09:15:00 PM
Lingerie Fighting Championships Coming to the UK for July 4 & 6 Events • BOTY • May 19, 2025 10:00 AM
VAYK Projects to Report Over $400K Q1 Revenue • VAYK • May 15, 2025 9:00 AM
Veri Medtech (VRHI) Reaches $100 Million Revenue Milestone • VRHI • May 15, 2025 8:00 AM
Cannabix Enters Sales Distribution Agreement with Australian Distributor for BreathLogix Autonomous Alcohol Breathalyzer • BLO • May 14, 2025 8:51 AM
North Bay Resources Announces Resource Estimate of 474,000 ounces at Fran Gold Project, British Columbia • NBRI • May 13, 2025 9:58 AM
UC Asset Filed for Public Offering of 8% Dividend Preferred Units • UCASU • May 12, 2025 9:55 AM